The Centre for Bioengineering and Biotechnology along and the University of Waterloo Office of Research are pleased to announce that Professor Karim S. Karim has accepted the role of Executive Director for a term of five years, ending March 31, 2025.
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.
The current COVID-19 pandemic has been putting a strain on healthcare workers around the world. We often forget all the challenges that frontline healthcare professionals have to face, including the use of personal protective equipment. This paper from 2016 describes the evaluation during the ebola crisis, which has excellent recommendations for healthcare workers and managers around the world when dealing with COVID-19.
The Health Canada Regulatory Insights Workshop 2019 was held on November 15, 2019 and was attended by 120+ researchers, industry professionals and students. Hosted by the Centre for Bioengineering and Biotechnology, this unique event was in response to a pressing need for clarity and information regarding Health Canada regulatory processes and evaluations. The event featured two guest speakers from Health Canada, a panel moderated by CBB member George Shaker, and networking opportunities with leading health industry professionals.
We have an intimate relationship with technology. It is infused in our daily life, from our home and car to our finances and health care. As we welcome new technologies into our most personal spaces, there is a growing recognition that design-based thinking needs to consider ethics and the users it serves.